Concepedia

Wei Tang

WT

Statistics

Publications

43

Citations

2.2K

H-Index

24

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of British Columbia

Merck Biopharma Co., Ltd. (Japan)

Wei Tang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and pharmacy.

ORCID

Publications per year

1995–2024

43

Publications

43

Studies on the Metabolism of Troglitazone to Reactive Intermediates in Vitro and in Vivo. Evidence for Novel Biotransformation Pathways Involving Quinone Methide Formation and Thiazolidinedione Ring Scission

Kelem Kassahun, Paul G. Pearson, Wei Tang et al. · Chemical Research in Toxicology · 2000 · 307 citations

, , +14

Studies on Cytochrome P-450-Mediated Bioactivation of Diclofenac in Rats and in Human Hepatocytes: Identification of Glutathione Conjugated Metabolites

Wei Tang, Ralph A. Stearns, Stelvio M. Bandiera et al. · Drug Metabolism and Disposition · 1999 · 170 citations

, , +17

Cytochrome P450 3A4-Mediated Bioactivation of Raloxifene:  Irreversible Enzyme Inhibition and Thiol Adduct Formation

Qing Chen, Jason S. Ngui, George A. Doss et al. · Chemical Research in Toxicology · 2002 · 156 citations

, , +17

Roles of Human Hepatic Cytochrome P450s 2C9 and 3A4 in the Metabolic Activation of Diclofenac

Wei Tang, Ralph A. Stearns, Regina W. Wang et al. · Chemical Research in Toxicology · 1999 · 154 citations

, , +17

In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4'- and 10-hydroxywarfarin.

Jason S. Ngui, Qing Chen, Magang Shou et al. · PubMed · 2001 · 98 citations

, , +17

1–5 of 43